Rezolute Inc (RZLT)

$3.12 +0.05 (1.63%)
Market Cap 293.79M
Revenue (ttm) 0.00
Net Income (ttm) -74.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,254,000
Avg Vol 2,365,510
Day's Range N/A - N/A
Shares Out 95.70M
Stochastic %K 20%
Beta 0.65
Analysts Strong Sell
Price Target $5.12

Company Profile

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 206 4507
Address:
275 Shoreline Drive, Suite 500, Redwood City, United States
MrBlockchain
MrBlockchain Apr. 29 at 3:35 PM
$RZLT Friday. 👍
0 · Reply
checkthef
checkthef Apr. 28 at 2:56 PM
$RZLT buying the dip here
0 · Reply
oaksapollo
oaksapollo Apr. 27 at 2:16 AM
$RZLT ad hoc analysis of Sunrize coming Friday morning. Let’s see what they got…
0 · Reply
KONGLIVES1
KONGLIVES1 Apr. 21 at 8:32 PM
$RZLT the stock is slowly dying, a slow death because of low volume 
1 · Reply
Monty3030
Monty3030 Apr. 21 at 7:38 PM
$RZLT 15.83 days to cover 18.79% short interest Let's see if we get a move in price within the next couple weeks.
0 · Reply
DARKP00L
DARKP00L Apr. 21 at 12:21 PM
$RZLT 07:23 on Apr. 21 2026 Rezolute Says Results From Phase 3 sunRIZE Study Of Ersodetug In Congenital HI Accepted For Oral Presentation At 2026 PES Annual Meeting #tradeideas
0 · Reply
oaksapollo
oaksapollo Apr. 21 at 12:02 PM
$RZLT looks like more cHI data coming next Friday. I’m not getting my hopes up too much.
0 · Reply
Monty3030
Monty3030 Apr. 21 at 11:36 AM
$RZLT https://ir.rezolutebio.com/news/detail/374/rezolute-to-present-results-from-its-phase-3-sunrize-study-in-congenital-hyperinsulinism-at-the-pediatric-endocrine-society-pes-annual-meeting
0 · Reply
KONGLIVES1
KONGLIVES1 Apr. 17 at 6:44 PM
$RZLT We need some volume to break out . This makes the price action on the stock quite vulnerable. Good luck to all enjoy the ride 
0 · Reply
Monty3030
Monty3030 Apr. 17 at 12:18 PM
$RZLT Market makers are eating up all the options expiring today. We had a low of $2.29 last month, so to be over $3.50 is good. Let's see what the next six weeks will bring.
0 · Reply
Latest News on RZLT
Rezolute, Inc. Investigated by the Portnoy Law Firm

Apr 24, 2026, 9:00 AM EDT - 5 days ago

Rezolute, Inc. Investigated by the Portnoy Law Firm

Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting

Apr 21, 2026, 7:00 AM EDT - 8 days ago

Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting

FDA Review Puts Rezolute's Genetic Disorder Drug Path In Question

Mar 24, 2026, 2:00 PM EDT - 5 weeks ago

FDA Review Puts Rezolute's Genetic Disorder Drug Path In Question

Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting

Mar 24, 2026, 7:00 AM EDT - 5 weeks ago

Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting

INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (RZLT)

Mar 5, 2026, 9:47 AM EST - 7 weeks ago

INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (RZLT)

Rezolute to Participate in the Citizens Life Sciences Conference

Mar 4, 2026, 7:00 AM EST - 2 months ago

Rezolute to Participate in the Citizens Life Sciences Conference

RZLT SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Mar 3, 2026, 9:10 AM EST - 2 months ago

RZLT SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Feb 28, 2026, 7:05 AM EST - 2 months ago

RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Feb 26, 2026, 9:40 AM EST - 2 months ago

INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Feb 17, 2026, 7:23 PM EST - 2 months ago

INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update

Feb 12, 2026, 4:05 PM EST - 2 months ago

Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Feb 10, 2026, 10:51 AM EST - 2 months ago

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating

Feb 9, 2026, 3:19 PM EST - 2 months ago

Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating

SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Feb 5, 2026, 5:09 PM EST - 2 months ago

SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Feb 4, 2026, 7:00 AM EST - 3 months ago

Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Jan 25, 2026, 8:21 PM EST - 3 months ago

INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Jan 16, 2026, 10:27 AM EST - 3 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Jan 8, 2026, 1:12 PM EST - 3 months ago

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism

Jan 7, 2026, 7:00 AM EST - 4 months ago

Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism

INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT

Jan 3, 2026, 7:41 AM EST - 4 months ago

INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT

INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT

Dec 31, 2025, 12:10 PM EST - 4 months ago

INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT

REZOLUTE INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT

Dec 19, 2025, 10:08 AM EST - 4 months ago

REZOLUTE INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT

RZLT: Rezolute, Inc. Investigated for Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

Dec 17, 2025, 4:31 PM EST - 4 months ago

RZLT: Rezolute, Inc. Investigated for Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

RZLT INVESTIGATION: Rezolute, Inc. Investors Should Contact Block & Leviton LLP To Potentially Recover Losses

Dec 12, 2025, 3:00 PM EST - 4 months ago

RZLT INVESTIGATION: Rezolute, Inc. Investors Should Contact Block & Leviton LLP To Potentially Recover Losses

Hagens Berman Investigating Rezolute, Inc. (RZLT) as Shares Tank 90% Amid Lead Asset Trial Failure

Dec 11, 2025, 7:59 PM EST - 4 months ago

Hagens Berman Investigating Rezolute, Inc. (RZLT) as Shares Tank 90% Amid Lead Asset Trial Failure

Rezolute, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – RZLT

Dec 11, 2025, 2:39 PM EST - 4 months ago

Rezolute, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – RZLT

BREAKING: Rezolute, Inc. Shares Down Over 85%; Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

Dec 11, 2025, 10:39 AM EST - 4 months ago

BREAKING: Rezolute, Inc. Shares Down Over 85%; Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

Rezolute Transcript: Study Result

Dec 11, 2025, 8:30 AM EST - 4 months ago

Rezolute Transcript: Study Result

Rezolute's rare disease drug fails main goal in late-stage trial

Dec 11, 2025, 7:05 AM EST - 4 months ago

Rezolute's rare disease drug fails main goal in late-stage trial

Rezolute Announces Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism

Dec 11, 2025, 7:00 AM EST - 4 months ago

Rezolute Announces Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism

Rezolute Transcript: AGM 2025

Nov 19, 2025, 6:00 PM EST - 5 months ago

Rezolute Transcript: AGM 2025

Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Nov 10, 2025, 5:30 PM EST - 6 months ago

Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Rezolute Transcript: Status Update

Nov 10, 2025, 12:00 PM EST - 6 months ago

Rezolute Transcript: Status Update

Rezolute Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

Nov 6, 2025, 4:05 PM EST - 6 months ago

Rezolute Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

Rezolute to Host Virtual Investor Event on Ersodetug Development Program

Nov 5, 2025, 7:30 AM EST - 6 months ago

Rezolute to Host Virtual Investor Event on Ersodetug Development Program

Rezolute to Participate in Upcoming Investor Conferences

Oct 15, 2025, 8:00 AM EDT - 7 months ago

Rezolute to Participate in Upcoming Investor Conferences

Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update

Sep 17, 2025, 4:05 PM EDT - 8 months ago

Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update

Rezolute Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 9, 2025, 12:20 PM EDT - 8 months ago

Rezolute Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism

Sep 2, 2025, 7:30 AM EDT - 8 months ago

Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism

Rezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer

Aug 20, 2025, 7:30 AM EDT - 9 months ago

Rezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer

Rezolute to Participate in the BTIG Virtual Biotechnology Conference

Jul 22, 2025, 7:30 AM EDT - 10 months ago

Rezolute to Participate in the BTIG Virtual Biotechnology Conference

Rezolute Announces Presentation of Participant Baseline Data from its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society (ENDO 2025)

Jul 9, 2025, 7:30 AM EDT - 10 months ago

Rezolute Announces Presentation of Participant Baseline Data from its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society (ENDO 2025)

Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism

May 28, 2025, 8:00 AM EDT - 1 year ago

Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism

Rezolute Transcript: AGM 2024

Dec 5, 2024, 6:00 PM EST - 1 year ago

Rezolute Transcript: AGM 2024

Rezolute Transcript: Guggenheim Securities Inaugural Healthcare Innovation Conference

Nov 13, 2024, 1:30 PM EST - 1 year ago

Rezolute Transcript: Guggenheim Securities Inaugural Healthcare Innovation Conference

Rezolute Transcript: Study Result

May 21, 2024, 5:30 PM EDT - 2 years ago

Rezolute Transcript: Study Result

Rezolute Transcript: AGM 2024

May 16, 2024, 6:00 PM EDT - 2 years ago

Rezolute Transcript: AGM 2024

Rezolute Transcript: Status Update

Jun 27, 2023, 4:30 PM EDT - 3 years ago

Rezolute Transcript: Status Update

Rezolute Transcript: AGM 2023

May 25, 2023, 6:00 PM EDT - 3 years ago

Rezolute Transcript: AGM 2023

Rezolute Transcript: Status Update

Mar 22, 2023, 4:30 PM EDT - 3 years ago

Rezolute Transcript: Status Update

Rezolute Transcript: Study Update

May 4, 2022, 4:30 PM EDT - 4 years ago

Rezolute Transcript: Study Update

Rezolute Transcript: Study Update

May 1, 2022, 2:30 PM EDT - 4 years ago

Rezolute Transcript: Study Update

MrBlockchain
MrBlockchain Apr. 29 at 3:35 PM
$RZLT Friday. 👍
0 · Reply
checkthef
checkthef Apr. 28 at 2:56 PM
$RZLT buying the dip here
0 · Reply
oaksapollo
oaksapollo Apr. 27 at 2:16 AM
$RZLT ad hoc analysis of Sunrize coming Friday morning. Let’s see what they got…
0 · Reply
KONGLIVES1
KONGLIVES1 Apr. 21 at 8:32 PM
$RZLT the stock is slowly dying, a slow death because of low volume 
1 · Reply
Monty3030
Monty3030 Apr. 21 at 7:38 PM
$RZLT 15.83 days to cover 18.79% short interest Let's see if we get a move in price within the next couple weeks.
0 · Reply
DARKP00L
DARKP00L Apr. 21 at 12:21 PM
$RZLT 07:23 on Apr. 21 2026 Rezolute Says Results From Phase 3 sunRIZE Study Of Ersodetug In Congenital HI Accepted For Oral Presentation At 2026 PES Annual Meeting #tradeideas
0 · Reply
oaksapollo
oaksapollo Apr. 21 at 12:02 PM
$RZLT looks like more cHI data coming next Friday. I’m not getting my hopes up too much.
0 · Reply
Monty3030
Monty3030 Apr. 21 at 11:36 AM
$RZLT https://ir.rezolutebio.com/news/detail/374/rezolute-to-present-results-from-its-phase-3-sunrize-study-in-congenital-hyperinsulinism-at-the-pediatric-endocrine-society-pes-annual-meeting
0 · Reply
KONGLIVES1
KONGLIVES1 Apr. 17 at 6:44 PM
$RZLT We need some volume to break out . This makes the price action on the stock quite vulnerable. Good luck to all enjoy the ride 
0 · Reply
Monty3030
Monty3030 Apr. 17 at 12:18 PM
$RZLT Market makers are eating up all the options expiring today. We had a low of $2.29 last month, so to be over $3.50 is good. Let's see what the next six weeks will bring.
0 · Reply
oaksapollo
oaksapollo Apr. 17 at 12:55 AM
$RZLT man this is so boring. They need to announce more dialed in timing for the tumor HI study. Is it July or December?! They must have some idea by now.
0 · Reply
dolloardollarbillyyall1
dolloardollarbillyyall1 Apr. 16 at 2:12 PM
$AMFN $ECOX $BURU $RZLT $SAFX These have been one big basket of dissapointment lately. LFG!
1 · Reply
KONGLIVES1
KONGLIVES1 Apr. 15 at 3:16 PM
$RZLT We need to see. more volume to break out above four on our way to five good luck to all enjoy the ride  good luck to all enjoy the ride 
0 · Reply
KONGLIVES1
KONGLIVES1 Apr. 13 at 7:15 PM
$RZLT the stock keeps ticking higher and higher in these times this is a huge positive. Good luck to all. Enjoy the ride 
0 · Reply
Monty3030
Monty3030 Apr. 8 at 1:32 AM
$RZLT 14.98 days to cover 23.84% short interest
0 · Reply
Monty3030
Monty3030 Apr. 7 at 10:37 PM
$RZLT Ceasefire for two weeks!! Now let's go!!
0 · Reply
Monty3030
Monty3030 Apr. 7 at 2:18 PM
$RZLT Everything is in a holding pattern until we find out about a resolution for this Iran war.
0 · Reply
oaksapollo
oaksapollo Apr. 6 at 6:11 PM
$RZLT seems like this is guaranteed to be dead money until late 2026 when tumor HI reads out and when we get clarity on cHI. Anyone else see it differently?
1 · Reply
MrBlockchain
MrBlockchain Apr. 1 at 1:44 PM
$RZLT Simple math here makes it seem like musical chairs.
1 · Reply
oaksapollo
oaksapollo Apr. 1 at 1:07 AM
$RZLT Mr. Evans bought even more https://www.sec.gov/Archives/edgar/data/1509261/000091228226000533/xslF345X06/form4.xml
1 · Reply
Monty3030
Monty3030 Mar. 31 at 9:13 PM
$RZLT Looking forward to a nice little run for the month of April!
0 · Reply
Monty3030
Monty3030 Mar. 31 at 9:11 PM
$RZLT More insider buying from the CFO filed today! 10k more shares
0 · Reply